A paradigm shift in schizophrenia treatment is focusing on the glutamate system for new agents to address all symptom domains. Learn what adjunctive agents are in development to treat negative and cognitive symptoms as well as agents that work through different pathways.

READ FULL ARTICLE Curated publisher From http://www.cmeinstitute.com/psychlopedia/psychosis/9mbs/sec6/section.asp